{"title":"ASCO 21 -肾癌推荐摘要","authors":"R. Figlin","doi":"10.52733/kcj19n2-s1-a16","DOIUrl":null,"url":null,"abstract":"These recommended abstracts have been selected by Robert A. Figlin, MD, Editor-in- Chief. The chosen abstracts provided here highlight some of the most important trends in ongoing trials and reflect the foremost research and strategies from latest clinical trials that impact the current standard of care in renal cancer","PeriodicalId":74040,"journal":{"name":"Kidney cancer journal : official journal of the Kidney Cancer Association","volume":"179 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"ASCO 21 - Recommended Abstracts in Kidney Cancer\",\"authors\":\"R. Figlin\",\"doi\":\"10.52733/kcj19n2-s1-a16\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"These recommended abstracts have been selected by Robert A. Figlin, MD, Editor-in- Chief. The chosen abstracts provided here highlight some of the most important trends in ongoing trials and reflect the foremost research and strategies from latest clinical trials that impact the current standard of care in renal cancer\",\"PeriodicalId\":74040,\"journal\":{\"name\":\"Kidney cancer journal : official journal of the Kidney Cancer Association\",\"volume\":\"179 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-06-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kidney cancer journal : official journal of the Kidney Cancer Association\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.52733/kcj19n2-s1-a16\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney cancer journal : official journal of the Kidney Cancer Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52733/kcj19n2-s1-a16","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
这些推荐的摘要是由主编，医学博士Robert A. Figlin挑选出来的。这里提供的精选摘要突出了正在进行的试验中一些最重要的趋势，反映了影响当前肾癌护理标准的最新临床试验的最重要的研究和策略
These recommended abstracts have been selected by Robert A. Figlin, MD, Editor-in- Chief. The chosen abstracts provided here highlight some of the most important trends in ongoing trials and reflect the foremost research and strategies from latest clinical trials that impact the current standard of care in renal cancer
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
